Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity.
about
Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group.MCEF is localized to the nucleus by protein sequences encoded within three distinct exons, where it represses HIV-1 Tat-transactivation of LTR-directed transcriptionInhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligandsOTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regionsMolecular basis for a lack of correlation between viral fitness and cell killing capacityCell-cycle and suppressor proteins expression in uterine cervix in HIV/HPV co-infection: comparative study by tissue micro-array (TMA).Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation.Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I.Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription.Genetic variation and HIV-associated neurologic disease.Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell linesAn upstream YY1 binding site on the HIV-1 LTR contributes to latent infection.Identification and functional analysis of a second RBF-2 binding site within the HIV-1 promoterGenotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection.HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease SeverityNef functions in BLT mice to enhance HIV-1 replication and deplete CD4+CD8+ thymocytes.Sequence insertions in the HIV type 1 subtype C viral promoter predominantly generate an additional NF-κB binding siteMultiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance.Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integrationMutations generated in human immunodeficiency virus type 1 long terminal repeat during vertical transmission correlate with viral gene expression.In search of a function for the most frequent naturally-occurring length polymorphism (MFNLP) of the HIV-1 LTR: retaining functional coupling, of Nef and RBF-2, at RBEIII?Genotypic and phenotypic heterogeneity in the U3R region of HIV type 1 subtype C.TFII-I regulates induction of chromosomally integrated human immunodeficiency virus type 1 long terminal repeat in cooperation with USF.CTGC motifs within the HIV core promoter specify Tat-responsive pre-initiation complexes.E box motifs as mediators of proviral latency of human retroviruses.Distinctive variation in the U3R region of the 5' Long Terminal Repeat from diverse HIV-1 strains.
P2860
Q24524085-4B8D23D8-5CF8-47BC-A43B-850D596F026BQ24680998-DE484D21-5581-417F-8976-5D1EBF642D57Q28369113-45EC1B15-A8B4-4140-A309-EA016816C161Q31814830-7AEF9958-1EF3-40FA-89A0-8731C4768659Q33282045-25627EAB-F2C4-46F6-9A5B-2584D4D2C5ACQ33374407-8BB09915-3DE8-415D-8465-509F45C13625Q33425135-DABBBCB1-AAF3-4B8F-B1D6-77BE3006FAD6Q33716931-926F34A0-FC8A-4E37-B66E-1D2FEEC57B38Q33783417-C4F92B9E-F4BA-4FBB-9197-4F1BF8684CDAQ33819189-A3AFDFA4-A6A2-49E8-99D4-5A625AB976EBQ34387337-659327E9-5F7F-4213-A4A4-764C41783EE3Q34465453-451895E6-B4A7-4A3E-9D38-61013FD30E93Q35015033-5895A492-DD87-4ECE-BDB3-23587789B3E6Q35222092-8CB2FA77-0605-43FF-A9FF-B43A86A77D76Q35888785-05A6142E-C10D-4DA6-B241-38A58B1B1895Q35995791-65D41ECD-379B-44CC-8FB2-D052FE17529EQ36112824-C8222034-88EE-4A68-8EFC-D638AA9C1CA5Q36250427-58D2DA9E-3996-4263-B37A-064A88197F8AQ36492916-8A72836D-267E-464C-A1EE-16842762C329Q36684330-2AE1A8D3-B98E-4E33-A40B-4E4402D7EB99Q36724734-760305D0-D786-4C6C-BB4D-BA9607B140ADQ36858891-50BCFBD2-2E4A-46BF-856E-1292CE5C2A60Q37460075-74FD9A97-7004-4BF0-B39B-FAE1878409DEQ41890044-A3341943-0FD9-4367-83D7-44A7A789D6E9Q41935503-187AA56D-2B55-4537-B19B-B0C8ACDF1F60Q42563241-3D67EDE4-B9FA-4F47-9487-5147967F7418Q53692218-8B9E2BD7-E42D-4BDC-9022-590C1D628CAC
P2860
Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Human immunodeficiency virus t ...... sm and transcription activity.
@ast
Human immunodeficiency virus t ...... sm and transcription activity.
@en
type
label
Human immunodeficiency virus t ...... sm and transcription activity.
@ast
Human immunodeficiency virus t ...... sm and transcription activity.
@en
prefLabel
Human immunodeficiency virus t ...... sm and transcription activity.
@ast
Human immunodeficiency virus t ...... sm and transcription activity.
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus t ...... ism and transcription activity
@en
P2093
Estable MC
Merzouki A
Montaner JS
O'Shaughnessy MV
Sadowski IJ
P2860
P304
P407
P577
1996-06-01T00:00:00Z